Sjögren's syndrome, the old and the new

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 1, 2012, Pages 105-117

  Peri, Yogev ^a   Agmon Levin, Nancy ^a   Theodor, Emanuel ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Autoimmunity; Biological therapies; Neuropathy; Sj gren's syndrome

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; B CELL ACTIVATING FACTOR; CYCLOSPORIN A; EPRATUZUMAB; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; HLA DR5 ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STAT4 PROTEIN; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTHRALGIA; ATROPHIC GASTRITIS; B CELL LYMPHOMA; CELIAC DISEASE; CHEILITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATITIS; DRY EYE; DYSPEPSIA; DYSPHAGIA; EPIGASTRIC PAIN; EYELID DISEASE; FATIGUE; FEVER; FIBROMYALGIA; GENE EXPRESSION; HUMAN; IMMUNE DYSREGULATION; INTERSTITIAL LUNG DISEASE; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE ACIDOSIS; NAUSEA; NERVE STIMULATION; NONHUMAN; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SJOEGREN SYNDROME; TH17 CELL; THYROID DISEASE; VASCULITIS; XEROSIS; XEROSTOMIA;

AUTOANTIBODIES; AUTOIMMUNITY; HUMANS; SJOGREN'S SYNDROME;

EID: 84858377907     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.01.012     Document Type: Review

References (92)

1. C. Vitali, S. Bombardieri, and R. Jonsson Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Annals of Rheumatic Diseases 61 6 2002 554 558 (Pubitemid 34539104)
2. S.S. Kassan, and H.M. Moutsopoulos Clinical manifestations and early diagnosis of Sjögren syndrome Archives of Internal Medicine 164 12 2004 1275 1284 (Pubitemid 38828877)
3. K. Bayetto, and R.M. Logan Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management Australian Dental Journal 55 Suppl. 1 2010 39 47
4. N. Agmon-Levin, Z. Lian, and Y. Shoenfeld Explosion of autoimmune diseases and the mosaic of old and novel factors Cellular and Molecular Immunology 8 3 2011 189 192
5. K. Asmussen, V. Andersen, and G. Bendixen A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study Journal of Internal Medicine 239 6 1996 475 482
6. I. Al-Hashimi Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management Drugs and Aging 22 11 2005 887 899 (Pubitemid 41746572)
7. A.G. Tzioufas, and M. Voulgarelis Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias Best Practice and Research Clinical Rheumatology 21 6 2007 989 1010 (Pubitemid 350194037)
8. E. Bernacchi, L. Amato, and A. Parodi Sjögren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology Clinical and Experimental Rheumatology 22 1 2004 55
9. M. Ramos-Casals, J.M. Anaya, and M. García-Carrasco Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients Medicine (Baltimore) 83 2 2004 96 106 (Pubitemid 38524626)
10. R.I. Fox, and A.Y. Liu Sjögren's syndrome in dermatology Clinics in Dermatology 24 5 2006 393 413
11. H.J. Haga, and E. Peen A study of the arthritis pattern in primary Sjögren's syndrome Clinical and Experimental Rheumatology 25 1 2007 88 91 (Pubitemid 46477491)
12. B. Lindvall, A. Bengtsson, J. Ernerudh, and P. Eriksson Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain Journal of Rheumatology 29 4 2002 717 725 (Pubitemid 34303865)
13. P.P. Pavlakis, H. Alexopoulos, and M.L. Kosmidis Peripheral neuropathies in Sjogren syndrome: a new reappraisal Journal of Neurology, Neurosurgery and Psychiatry 82 7 2011 798 802
14. D. Sne, M. Jallouli, and J.P. Lefaucheur Peripheral neuropathies associated with primary Sjögren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy Medicine (Baltimore) 90 2 2011 133 138
15. J. Birnbaum Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies Neurologist 16 5 2010 287 297
16. A.L. Fauchais, L. Richard, and G. Gondran Small fibre neuropathy in primary Sjögren syndrome La Revue de médecine interne 32 3 2011 142 148
17. S.M. Yan, Y. Zhao, and X.F. Zeng Lung involvement of primary Sjögren's syndrome Zhonghua Jie He He Hu Xi Za Zhi 31 7 2008 513 516
18. S. Maripuri, J.P. Grande, and T.G. Osborn Renal involvement in primary Sjögren's syndrome: a clinicopathologic study Clinical Journal of American Society for Nephrology 4 9 2009 1423 1431
19. T. Fujimoto, and K. Dohi Renal involvement in Sjögren's syndrome-interstitial nephritis and glomerulonephritis Nihon Rinsho 53 10 1995 2495 2502
20. M. Pertovaara, M. Korpela, and A. Pasternack Factors predictive of renal involvement in patients with primary Sjögren's syndrome Clinical Nephrology 56 2001 8 10
21. P. Szodoray, Z. Barta, and G. Lakos Coeliac disease in Sjögren's syndrome-a study of 111 Hungarian patients Rheumatology International 24 5 2004 278 282 (Pubitemid 39286909)
22. L.J. Jara, C. Navarro, and P. Brito-Zerón Mdel Thyroid disease in Sjögren's syndrome Clinical Rheumatology 26 10 2007 1601 1606
23. K. Ekström Smedby, C.M. Vajdic, and M. Falster Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the Inter Lymph Consortium Blood 111 8 2008 4029 4038
24. J.P. Ioannidis, V.A. Vassiliou, and H.M. Moutsopoulos Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome Arthritis and Rheumatism 46 3 2002 741 747 (Pubitemid 34214255)
25. C. Vitali, S. Bombardieri, and H.M. Moutsopoulos Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community Arthritis and Rheumatism 36 1993 340 347 (Pubitemid 23090601)
26. J. Gálvez, E. Sáiz, and P. López Diagnostic evaluation and classification criteria in Sjögren's Syndrome Joint Bone Spine 76 1 2009 44 49
27. H. Takahashi, M. Yamamoto, and C. Suzuki The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity Autoimmunity Reviews 9 9 2010 591 594
28. Y. Masaki, L. Dong, and N. Kurose Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders Annals of Rheumatic Diseases 68 8 2009 1310 1315
29. T. Witte Diagnostic markers of Sjögren's syndrome Developments in Ophthalmology 45 2010 123 128
30. E.J. Ter Borg, A.P. Risselada, and J.C. Kelder Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands Seminars in Arthritis and Rheumatism 40 6 2011 547 551
31. G. Hernández-Molina, G. Leal-Alegre, and M. Michel-Peregrina The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome Autoimmunity Reviews 10 3 2011 123 125
32. M.R. Arbuckle, M.T. McClain, and M.V. Rubertone Development of autoantibodies before the clinical onset of systemic lupus erythematosus New England Journal of Medicine 349 16 2003 Oct 16 1526 1533 (Pubitemid 37255038)
33. T.E. Daniels Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases Arthritis and Rheumatism 27 2 1984 147 156 (Pubitemid 14191019)
34. C.P. Mavragani, and H.M. Moutsopoulos The geoepidemiology of Sjögren's syndrome Autoimmunity Reviews 9 5 2010 A305 A310
35. Y. Shapira, N. Agmon-Levin, and Y. Shoenfeld Geoepidemiology of autoimmune rheumatic diseases Nature Reviews Rheumatology 6 8 2010 468 476
36. D.F. Lin, S.M. Yan, and Y. Zhao Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome Chinese Medical Journal (English) 123 22 2010 3252 3257
37. A.I. Bolstad, H.J. Haga, and R. Wassmuth Monozygotic twins with primary Sjogren's syndrome Journal of Rheumatology 27 9 2000 2264 2266
38. L.A. Criswell, K.A. Pfeiffer, and R.F. Lum Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620 W allele associates with multiple autoimmune phenotypes American Journal of Human Genetics 76 4 2005 561 571 (Pubitemid 40432164)
39. Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM. HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmunity Reviews, in press.
40. A. Roitberg-Tambur, A. Friedmann, and C. Safirman Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients Human Immunology 36 4 1993 235 242 (Pubitemid 23170021)
41. G. Nordmark, G. Kristjansdottir, and E. Theander Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome Genes and Immunity 10 2009 68 76
42. C. Miceli-Richard, N. Gestermann, and M. Ittah The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome Arthritis and Rheumatism 60 2009 1991 1997
43. B.D. Korman, M.I. Alba, and J.M. Le Variant form of STAT4 is associated with primary Sjogren's syndrome Genes and Immunity 9 3 2008 267 270 (Pubitemid 351584194)
44. E.F. Remmers, R.M. Plenge, and A.T. Lee STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus New England Journal of Medicine 357 10 2007 977 986 (Pubitemid 47367077)
45. O. Kimoto, J. Sawada, and K. Shimoyama Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome Journal of Rheumatology 38 2 2011 310 316
46. J. Hulkkonen, M. Pertovaara, and J. Antonen Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease Rheumatology (Oxford) 40 6 2001 656 661
47. G.J. Shim, M. Warner, and H.J. Kim Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren's syndrome Proceeding of the National Academy of Sciences of USA 101 2004 12628 12633 (Pubitemid 39127516)
48. M. Spaan, P. Porola, and M. Laine Healthy human salivary glands contain a DHEA-S processing intracrine machinery, which is deranged in primary Sjogren's syndrome Journal of Cellular and Molecular Medicine 13 7 2009 1261 1270
49. S.T. Valtysdottir, L. Wide, and R. Hallgren Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function Journal of Rheumatology 28 2001 1259 1265 (Pubitemid 32510496)
50. L.J. Jara, G. Medina, and M.A. Saavedra Prolactin and autoimmunity Clinical Reviews in Allergy Immunology 40 1 2011 50 59
51. Y.M. El Miedany, I. Ahmed, and H. Moustafa Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine 71 2004 203 208 (Pubitemid 38739130)
52. E. Toubi, and Y. Shoenfeld The role of vitamin D in regulating immune responses Israel Medical Association Journal 12 3 2010 174 175
53. P. Szodoray, I.F. Horvath, and G. Papp The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome Rheumatology (Oxford) 49 2 2010 211 217
54. S. Kivity, N. Agmon-Levin, M. Blank, and Y. Shoenfeld Infections and autoimmunity-friends or foes? Trends in Immunology 30 8 2009 409 414
55. A. Hida, M. Imaizumi, and N. Sera Association of human T lymphotropic virus type I with Sjogren syndrome Annals of Rheumatic Diseases 69 11 2010 2056 2057
56. E. Toussirot, and J. Roudier Epstein-Barr virus in autoimmune diseases Best Practice and Research Clinical Rheumatology 22 5 2008 883 896
57. J. Haddad, P. Deny, and Munz-Gotheil Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease Lancet 339 8789 1992 321 323
58. C.P. Mavragani, and M.K. Crow Activation of the type I interferon pathway in primary Sjogren's syndrome Journal of Autoimmunity 35 3 2010 225 231
59. K.M. Vakaloglou, and C.P. Mavragani Activation of the type I interferon pathway in primary Sjögren's syndrome: an update Current Opinion in Rheumatology 23 5 2011 459 464
60. J.E. Gottenberg, N. Cagnard, and C. Lucchesi Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome Proceeding of the National Academy of Sciences of USA 103 2006 2770 2775
61. M.M. Varin, L. Le Pottier, and P. Youinou B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF Autoimmunity Reviews 9 9 2010 604 608
62. J.L. Vosters, M.A. Landek-Salgado, and H. Yin Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome Arthritis and Rheumatism 60 12 2009 3633 3641
63. R.I. Fox Sjögren's syndrome: immunobiology of exocrine gland dysfunction Advances in Dental Research 10 1 1996 35 40
64. R. Jonsson, P. Vogelsang, and R. Volchenkov The complexity of Sjögren's syndrome: novel aspects on pathogenesis Immunology Letters 141 1 2011 Dec 30 1 9
65. L.J. Dawson, J. Stanbury, and N. Venn Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells Arthritis and Rheumatism 54 2006 1165 1173 (Pubitemid 43672929)
66. S. Steinfeld, E. Cogan, and L.S. King Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients Laboratory Investigation 81 2001 143 148 (Pubitemid 32176377)
67. S.D. Steinfeld, T.A. Appelboom, and C. Delporte Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome Arthritis and Rheumatism 46 2002 2249 2251
68. K. Haldorsen, K. Moen, and H. Jacobsen Exocrine function in primary Sjögren syndrome: natural course and prognostic factors Annals of Rheumatic Diseases 67 7 2008 949 954 (Pubitemid 351956656)
69. P. Brito-Zerón, and M. Ramos-Casals Prognosis of patients with primary Sjögren's syndrome Medicina Clinica (Barc) 130 3 2008 109 115 2 (Pubitemid 351362738)
70. P. Brito-Zerón, M. Ramos-Casals, and A. Bove Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors Rheumatology (Oxford) 46 8 2007 1359 1362 (Pubitemid 47244514)
71. R. Seror, P. Ravaud, and S.J. Bowman EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome Annals of Rheumatic Diseases 69 6 2010 1103 1109
72. R. Seror, P. Ravaud, and X. Mariette EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome Annals of Rheumatic Diseases 70 6 2011 968 972
73. F.B. Vivino, I. Al-Hashimi, and Z. Khan Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome Archives of Internal Medicine 159 1999 174 181
74. K. Sall, O.D. Stevenson, T.K. Mundorf, and B.L. Reis Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 4 2000 631 639 (Pubitemid 30191329)
75. F.P. Strietzel, G.I. Lafaurie, and G.R. Bautista Mendoza Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial Arthritis and Rheumatism 63 2011 180 190
76. R. Shacham, M.B. Puterman, N. Ohana, and O. Nahlieli Endoscopic treatment of salivary glands affected by autoimmune diseases Journal of Oral and Maxillofacial Surgery 69 2 2011 476 481
77. M. Ramos-Casals, G.A. Tzioufas, and H.J. Stone Treatment of primary sjogren syndrome, a systematic review Journal of Aerican Medical Association 304 4 2010 452 460
78. A.A. Kruize, R.J. Hené, and C.G. Kallenberg Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial Annals of Rheumatic Diseases 52 1993 360 364 (Pubitemid 23165974)
79. M. Keikp, L. Masahiro, and K. Haruki The wide spectrum of clinical manifestations in sjogren's syndrome-associated neuropathy Brain 128 11 2005 2518 2534
80. S. Delalande, J. de Seze, and A.L. Fauchais Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients Medicine (Baltimore) 83 5 2004 280 291 (Pubitemid 39258414)
81. Y. Levy, Y. Uziel, and G. Zandman Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis Annals of Rheumatic Diseases 62 12 2003 1221 1223 (Pubitemid 37500632)
82. A. Joseph, R. Brasington, and L. Kahl Immunologic rheumatic disorders Journal of Allergy and Clinical Immunology 125 Suppl. 2 2010 S204 S215
83. M. Ramos Casals, P. Brito-Zerón, and S. Muñoz A systematic review of the off-label use of biological therapies in systemic autoimmune diseases Medicine (Baltimore) 87 6 2008 345 364
84. G.J. Tobón, J.O. Pers, P. Youinou, and A. Saraux B cell targeted therapies in sjogren syndrome Autoimmunity Reviews 9 4 2010 224 228
85. A. Saraux The point on the ongoing B cell depleting trials Autoimmunity Reviews 9 9 2010 609 614
86. J.M. Meijer, A. Meiners, and F.K.L. Vissinik Effectiveness of rituximab treatment in primary sjogren's syndrome Arthritis and Rheumatism 62 4 2010 960 968
87. J.M. Meijer, J. Pijpe, and A. Vissinik Treatment of primary sjogren's syndrome with rituximab:extended follow up. Safety and efficacy of retreatment Annals of Rheumatic Diseases 68 2 2009 284 285
88. A. Mekinian, P. Ravaud, and P.Y. Hatron Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry Annals of Rheumatic Diseases 71 1 2012 84 87
89. J. Pijpe, J.M. Meijers, and H. Bootsma Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome Arthritis and Rheumatism 60 11 2009 3251 3256
90. T. Dörner, and M.D. Goldenberg Targeting CD22 as a strategy for treating systemic autoimmune diseases Therapeutic and Clinical Risk Management 3 5 2007 953 959 (Pubitemid 350162093)
91. H.M. Horton, S.Y. Chu, and E.C. Ortiz Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Journal of Immunology 186 7 2011 4223 4233
92. D. Mitsias, and H.M. Moutsopoulos Sjogren syndrome Diagnostic criteria in autoimmune diseases 1st ed. 2008 Humana press 37 43